Journals / Epilepsi / 2019 / Cilt: 25 - Sayı: 1

Perioperative Epileptic Seizure Incidence in Glioma Patients

Glioma Hastalarında Perioperatif Epileptik Nöbet İnsidansı

Journal
Epilepsi
Pages
21–26
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, despite the postoperative use of antiepileptic drugs in these subgroups, the incidence of epileptic seizures varied between 27% and 50%.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The aim of this study was to evaluate the incidence of epileptic seizures in the perioperative period in patients who were diagnosed with a glial tumor.
📊
Key Findings & Data:Methods: This was a retrospective clinical study of the hospital files of 39 patients diagnosed with glial tumors in a single clinic between January 2016 and March 2018 as well as the data of the first 3 months of postoperative control.
💡
Conclusion & Impact:However, despite the postoperative use of antiepileptic drugs in these subgroups, the incidence of epileptic seizures varied between 27% and 50%.
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: The aim of this study was to evaluate the incidence of epileptic seizures in the perioperative period in patients who were diagnosed with a glial tumor. Methods: This was a retrospective clinical study of the hospital files of 39 patients diagnosed with glial tumors in a single clinic between January 2016 and March 2018 as well as the data of the first 3 months of postoperative control. The glial tumor histopathological subgroup, presence of an isocitrate dehydrogenase mutation, radiological treatment feasibility of the site, deep or cortical location, and operative method were analyzed in relation to the incidence of epileptic seizures. Results: Of the 39 patients included in this study, the male/female ratio was 25/14. In all, 22 patients were diagnosed with a glial tumor after an epileptic seizure and 17 patients were initially examined for other complaints and subsequently diagnosed with a glial tumor. The functional field localization of the glial tumor in the preoperative period and the superficial location in the postoperative period were found to be statistically significant regarding epileptic seizure frequency. Conclusion: Functional level, superficial localization, World Health Organization grade II, and awake craniotomy were correlated with decreased incidence of postoperative seizures in glioma cases. However, despite the postoperative use of antiepileptic drugs in these subgroups, the incidence of epileptic seizures varied between 27% and 50%.

Özet

Amaç: Bu çalışmanın amacı, glial tümör tanısıyla ameliyat edilen hastalarda epileptik nöbet insidansının, ameliyat öncesi ve ameliyat sonrası dönem içinde değerlendirilmesidir. Gereç ve Yöntem: Bu çalışma, Ocak 2016–Mart 2018 arasında kliniğimizde glial tümör tanısıyla opere edilen 39 hastanın dosya ve ilk üç aylık kontrol verilerinin değerlendirilmesiyle elde edilen verilere dayalı geriye dönük klinik bir çalışmadır. Glial tümör histopatolojik alt grup, IDHmutasyon varlığı, radyolojik olarak fonksiyonel saha, derin veya kortikal yerleşim, uygulanan ameliyat yöntemi gibi değişkenlerde görülen epileptik nöbet insidansı araştırılmıştır. Bulgular: Glial tümör nedeniyle opere edilen ve çalışmaya dahil edilen 39 hasta için erkek/kadın oranı 25/14’dür. Yirmi iki hastaya epileptik nöbet sonrasında, 17 hastaya diğer şikayetler üzerine tanı araştırılarak glial tümör tanısı konmuştur. Ameliyat öncesi dönemde glial tümörlü olgularda fonksiyonel saha yerleşimi, ameliyat sonrası dönemde yüzeyel tümör yerleşimi epileptik nöbet sıklığında istatiksel olarak anlamlı yüksek bulunmuştur. Sonuç: Fonksiyonel alan, yüzeyel yerleşimli, WHO derece II, uyanık kraniotomi uygulanan glioma olgularında ameliyat sonrası nöbet insidansı azalmaktadır. Fakat ameliyat sonrası dönemde bu altgruplarda antiepileptik ilaç kullanılmasına rağmen, epileptik nöbet insidansı %27–50 aralığında değişmektedir.

🔖

Cite This Article

AKAY, A., İŞLEKEL, S. (2019). Perioperative Epileptic Seizure Incidence in Glioma Patients. Epilepsi, Cilt: 25 - Sayı: 1, 21–26. https://ajindex.com/articles/150782

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Englot DJ, Chang EF, Vecht CJ. Epilepsy and brain tumors. Handb Clin Neurol 2016;134:267–85.
  2. Chassoux F, Landre E. Prevention and management of postoperative seizures in neurooncology. Neurochirurgie 2017;63(3):197–203.
  3. Vecht CJ, Wilms EB. Seizures in low and high grade gliomas: current management and future outlook. Expert Rev Anticancer Ther 2010;10(5):663–9.
  4. Akay A, Islekel S. Awake Craniotomy Procedure: Its Effects on Neurological Morbidity and Recommendations. Turk Neurosug 2018;29(2):186–92.
  5. Glantz M, Cole BF, Forsyth PA, Recth LD, Wen PY, Chamberlain MC, et al. Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;54(10):1886–93.
  6. Stupp R, Brada M, van den Bent MJ, Tonn JC, Pentheroudakis G; ESMO Guidelines Working Group. High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2014;25(3):93–101.
  7. Skardelly M, Rother C, Noell S, Behling F, Wuttke TV, Schitten Glioma helm J, et al. Predictors of preoperative and early postoperative seizures in patients with intraaxial primary and metastatic brain tumors: A retrospective observational single center study. Ann Neurol 2015;78(6):917–28.
  8. Wu AS, Trinh VT, Suki D, Graham S, Forman A, Weinberg JS, et al. A prospective randomized trial of perioperative seizure prophylaxis in patients with intraparenchymal brain tumors. J Neurosurg 2013;118(4):873–83.
  9. Rossetti AO, Stupp R. Epilepsy in brain tumor patients. Curr Opin Neurol 2010;23(6):603–9.
  10. Englot DJ, Berger MS, Chang EF, Garcia PA, et al. Characteristics and treatment of seizures in patients with high-grade glioma: a review. Neurosurg Clin N Am 2012;23(2):227–35.
  11. Iuchi T, Hasegawa Y, Kawasaki K, Sakaida T. Epilepsy in patients with gliomas: incidence and control of seizures. J Clin Neurosci 2015;22(1):87–91.
  12. Kerkhof M, Vecht CJ. Seizure characteristics and prognostic factors of gliomas. Epilepsia 2013;54(9):12–7.
  13. Lee JW, Wen PY, Hurwitz S, Black P, Kesari S, Drappatz J, et al. Morphological characteristics of brain tumors causing seizures. Arch Neurol 2010;67(3):336–42.
  14. Louis DN, Perry A, Reifenberger G, von Deimling A, FigarellaBranger D, Cavenee WK, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 2016;131(6):803–20.
  15. Feyissa AM, Worrell GA, Tatum WO, Mahato D, Brinkmann BH, Rosenfeld SS, et al. High-fre